Skip to Content


In the US, Cosentyx (secukinumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Ankylosing Spondylitis, Plaque Psoriasis and Psoriatic Arthritis.

US matches:

UK matches:

Ingredient matches for Cosentyx


Secukinumab is reported as an ingredient of Cosentyx in the following countries:

  • Croatia (Hrvatska)
  • Germany
  • Ireland
  • Slovakia
  • Switzerland
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.